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Summary – Objective: To examine anxiety and depression in opiate ad-
dicts treated with methadone and buprenorphine. Subjects and meth-
ods: The study was conducted in the Association 'Margina' and the Center
for Prevention and Out-patient Treatment of Addiction Diseases in Mostar.
It included 100 patients who were divided into two groups: the first group
consisted of drug subox- on users (N=50) and the other group consisted of
subjects addicted to methadone, which was divided into two subgroups: M
+ and M– (recurrent). For the purposes of the research, Beck 's Anxiety and
Depression Scale, Self-assessment Questionnaire for Anxiety (STAI),
socio-demographic questionnaire specifically made for this research and
Health Survey SF -36 (Short – Form Health Survey – 36th) were used. Re-
sults: Significantly higher numbers of addicts were living in the city (p =
0.034). The recurrent methadone users were significantly more depressed
(> 20 %), while this percentage was somewhat lower in SBX users and M +
subjects (20%). There was no statistically significant difference between
the latter two groups (p=0.216). SBX users displayed most anxiety (10 %),
while it was lowest among the users of methadone (<10 %). There was a
statistically significant difference between the users of methadone M+ and
M– (p = 0.034). Conclusion: Users of methadone were significantly more
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anxious than the drug buprenorphine users, while there were no statistically
significant differences between the groups considering the depression
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INTRODUCTION
Psychoactive substances represent a problem dating from the fifties and starting to
threaten the usual standards of life. People who get addicted to psychoactive sub-
stances become slaves of their problem and try to focus all their abilities towards pro-
viding a certain amount of psychoactive substance, weakening their integrity even
further. The average age when the substance is taken for the first time is about 15
years, first injection happens about 21 (18 in the age group 18–24), while the time of
the first addiction treatment ranges between 22–25 years of age.
It is a rule that an addict takes more substances at the same time, usually starting
with alcohol and marijuana and then quickly turning to opiates.1 Opiates include psy-
choactive substances of herbal origin, first of all opium, the driedmilky juice from the
not yet ripe fruits of white poppies, from which the morphine is later extracted. By
means of twice-acetallizing the morphine, heroin (half-synthetic drug) is produced.
This group also includes synthetic derivates of morphine, codeine and methadone,
with similar effect.2 Addiction to heroin is in most cases very difficult to cure. So
nowadays, it is usual to try to help the individuals and their families by means of re-
placing the expensive illegal psychoactive drug with narcotics heptanone (metha-
done) and buprenorphine. Patients receive these substances directly from their doc-
tors.3 Methadone is widely used in treating the addiction throughout the world since
1960, while it was introduced to Croatia in 1990. The effects of methadone differ
from the effects of other narcotics, because they last longer and there is no initial eu-
phoria. The effect of methadone lasts up to 24 hours, thus enabling the patients to take
it just once a day.4 The main effects of methadone are alleviating the craving, sup-
pressing the withdrawal symptoms and blocking the euphoric effect of opiates. It is a
paradox that the use of methadone has resulted in greater number of fatalities due to
the drug overdose.5 Buprenorphine is used as a substitution therapy in treating the
opiate addiction. It is used also as a substitution for methadone therapy if and when a
patient decides to stop taking methadone. As opposed to methadone, buprenorphine
may be given 3 times a week, enabling the users to have a better professional and so-
cial rehabilitation and generally, better quality of life. Higher doses of buprenorphine
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are better tolerated than high doses of methadone, seldom lead to the development of
tolerance and is less addictive than methadone.6
Anxiety
Anxiety is a painful state of helplessness and vulnerability. It is a state of being
tense, worried and expecting something terrible to happen. The feeling of anxiety,
along with accompanying organic and physiological disturbances, or more precisely,
with secretory and motoric discharge, overwhelms the person and in the most severe
cases, represents an unbearable state and an incomparable experience.7 Anxiety is a
constitutive part of life and we all feel it from time to time. We consider it a disease
only when the anxiety is always present (general anxiety disorder), happening in par-
ticular situations which are usually not frightening, i.e. entering an elevator or taking
a tram ride, leaving the house, social situations (phobias) or when it appears abruptly
as an attack of particularly strong feeling of anxiety, called panic (panic disorder) and
when that anxiety significantly limits the individual in achieving her/his personal,
professional and other goals in life, thus reducing the quality of life. Not all anxiety
should be feared, because it is common and informs the individual if he was in an
alarming situation.8
Anxiety is manifested with a variety of symptoms, such as heart thumping, sweat-
ing, tremor of hands and body, dry mouth, breathing difficulties, nausea, feeling
warm or hot, muscle tension, feeling that we are unable to relax and feeling of having
a globe in the throat. Furthermore, it is manifested by mental symptoms, such as feel-
ing of imminent fainting, weakness, confusion, concentrating difficulties, fear of
death. The patients report a fear that they will lose control over their actions, feel ex-
cessively worried and expect some unpleasant surprise to happen. Several factors in-
fluence the occurrence of anxiety, such as childhood experiences, stressful situations,
personal susceptibility and the manners of coping with stress.9
The treatment of each person suffering from anxiety disorder should be approached
individually and a specific plan of treatment tailored, consisting of medicamental
treatment, psychotherapeutic and other non-medicamental procedures and most fre-
quently, their combination. Whichever reasons lead to the development of anxiety,
their basis is in brain, because they are psychologically and biologically connected.
Thus, it is important to say that the anxiety disorders can be treated with drugs, partic-
ularly from the group of anti-depressants affecting the serotonin levels, which are also
successful in treatment of depression. It is important to point out that the drugs should
be taken continually throughout the period of several weeks, as prescribed.10
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Depression
Depression is a frequent mental disorder, characterized with sadness, loss of inter-
est or satisfaction, feeling of guilt or low self-esteem, sleep and appetite disturbances,
fatigue and lack of concentration. It is estimated that 350 millions of persons are suf-
fering from that illness. Etiology of depression can be studied through several theo-
retical models: cognitive, behavioral, connected with surroundings and probably the
most acceptable is the model diathesis-stress.
Cognitive model explains the depression by means of attributive styles which per-
son uses to explain the negative outcomes and begins with the cognitive triad, where
the depressive persons have a more negative perception of themselves (unsuccessful
person), negative perception of the world around them (superior and cruel) and nega-
tive expectations from the future. The behavioral model finds the causes of depres-
sion in problems due to personal interactions with the surroundings, where the limited
pleasant experiences, thoughts that promote sadness and lack of experiences improv-
ing the self-esteem contribute to the emotional discomfort. Among the classes of de-
pression, there are:
1. Unipolar depressions are characterized by typical depressive episodes, where a
person experiences depressive mood, loss of interest and satisfaction and lack of
energy, leading to decreased activity and lasting for no less than two weeks. De-
pending on the number and severity of symptoms, depressive episodes can be
mild, moderate or severe.
2. Bipolar mood disorder consists of manic and depressive episodes, separated
with periods of normal behaviour. Manic episodes include increased or height-
ened sense of irritability, hyperactivity, speaking tension, inflated self-esteem
and reduced need for sleep.11
Treatment is nowadays ever more shifted from the psychiatric hospitals towards
the treatment in families, which requires meeting several conditions. Among those
conditions, the most important are: early start of treatment, positive emotional atti-
tude towards the patient, informing the family about the nature of disease, support of
professional and wider social surroundings, positive attitude towards the treatment
and frequent controls etc.12
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The main aim of this study is to investigate anxiety and depression among the opi-
ate addicts treated with methadone and buprenorphine in the area of Mostar, in the
Association 'Margina' and Center for Prevention and Out-patient Treatment of Addic-
tion Diseases.
Specific aims: Investigate which between the users taking subox-on, methadone
M+ and M- (recurrent) are the most anxious. Investigate which between the users tak-
ing subox-on, methadone M+ and M- (recurrent) are the most depressed. Investigate
the health level of users taking subox-on, methadone M+ and M- (recurrent) Investi-
gate the number of users taking subox-on, methadone M+ and M- (recurrent) consid-
ering their sex, level of education and interpersonal relations.
Ethical implications
– Verbal acceptance of subjects to take the survey.
– Informing the group about the anonymity of the survey and confidentiality of
data.
– Informing the subjects about the aim and specific goals of the study.
– Stressing to subjects that the data will be used in scientific purposes (graduate
thesis).
– In agreement with heads of both centers, data analysis and conclusions will be
delivered to the centers.
SUBJECTS AND METHODS
The investigation was carried out in the Association 'Margina' and the Center for
Prevention and Out-patient Treatment of Addictions in Mostar in the period from 1st
July to 20th August in the year of 2013. For the purposes of the study, Beck's scale of
anxiety and depression (23), containing 21 questions about anxiety and 21 questions
about depression, State-Trait Anxiety Inventory (STAI) self-assessment question-
naire (24), socio-demographic questionnaire tailored specifically for the purposes of
this study and Short Form Health Survey-36 (25) were used. The study was done on
100 subjects of both sexes, 50 methadone addicts and 50 buprenorphine addicts, aged
from 23–49 years. Participation in the study was voluntary and included the subjects
of both sexes. Patients previously diagnosed with mental illnesses or mental retarda-
tion have been excluded from the study.
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Statistical data analysis
For the statistical analysis, we have used the program package SPSS for Windows
(Version 17.0., SPSS Inc, Chicago, Illinois, USA) and Microsoft Excel (Version
11.0., Microsoft Corporation, Redmond, WA, USA). All statistical data were ex-
pressed as percentages and shown by means of graphs and tables, calculated using the
program Microsoft Excel 2007. To assess the differences of nominal and ordinal vari-
ables, c2-test was used. Where the frequencies had not proved as expected, Yates' cor-
rection was applied and in some cases, merging of several cells. Level of significance
was set to p£0,05.
RESULTS
During the investigation, the total number of 100 subjects registered in the Associ-
ation 'Margina' and the Center for Prevention and Out-patient Treatment of Addic-
tions in Mostar have been questioned. 19 female subjects and 81 male subjects have
been tested.
The most obvious difference between the subjects divided according to sex was in
subox-on use – 87,9 % of male and 12,1 % of female subjects, while the difference in
methadone use was less apparent – 76,1 % of male and 23,9 % of female subjects The
difference in therapy choice between the sexes is statistically significant, because the
Pearson's coefficient equals p 0,420.
Users of subox-on mostly finished the secondary education (72,7%) while the
smaller percentage of them finished trade schools (3%) and universities (3%). As in
the previous group, the greatest percentage of methadone users had finished second-
ary school (58,7%)while a lesser percentage (6,5%) of them had graduated on univer-
sities or achieved a baccalaureate. The difference here is also statistically significant,
because the Pearson's coefficient equals p 0,471*.
In all three groups of subjects, namely users of subox-on, methadone users and re-
current users of methadone, most of the subjects have reported their standard of living
as average. SBX (54,5%), M+ (52,2%) and M– (47,6%). The smallest percentage of
users taking subox-on and methadone have reported their standard of living as above
average SBX (3%), M (0%), while the smallest number of recurrent methadone users
reported their standard of living equally as above average and 'cannot estimate' (4,8%).
The difference in Pearson's coefficients is obvious here and it equals p 0,813.*
In all three groups of subjects, namely users of subox-on, methadone and recurrent
users of methadone, most subjects have reported to live with their families. In SBX
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group, the percentage of those equaled 54,5%, while in methadone users it equaled
47.8% and 47,6% in recurrent methadone users. The smallest was the percentage of
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N % N % N %
Sex 1,736 0,420
F 4 12,1 11 23,9 4 19,0
M 29 87,9 35 76,1 17 81,0
Education 7,398 0,471*
Primary school 5 15,2 5 10,9 1 4,8
Secondary school 1 3,0 8 17,4 4 19,0
Trade school 24 72,7 27 58,7 15 71,4
University baccalaureate 2 6,1 3 6,5 1 4,8
University diploma 1 3,0 3 6,5 0 0,0
Standard 6,363 0,813*
Above average 1 3,0 0 0,0 1 4,8
Slightly above average 2 6,1 3 6,5 0 0,0
Average 18 54,5 24 52,2 10 47,6
Slightly below average 6 18,2 10 21,7 3 14,3
Significantly lower than average 4 12,1 7 15,2 6 28,6
Cannot estimate 2 6,1 2 4,3 1 4,8
Living with 4,123 0,873*
Alone 7 21,2 13 28,3 5 23,8
With family 18 54,5 22 47,8 10 47,6
With one parent 3 9,1 3 6,5 4 19,0
With relatives 1 3,0 2 4,3 1 4,8
With friends 4 12,1 6 13,0 1 4,8
Living in 5,997 0,034*
Country 0 0,0 7 15,2 1 4,8
City 33 100,0 39 84,8 20 95,2
*Fisher's exact test; SBX-Subox-on; M+ Methadone group (stable); M– Methadone group (re-
current)
those who live with their relatives, 3% in SBX group, 4,3% in methadone users group
and 4,8% in recurrent methadone users group. The same percentage of the latter
group reported living with their friends. Pearson's coefficient equaled p= 0,873.
100% of subox-on users live in the city, while that percentage is slightly smaller for
methadone users (84,8 %) and the recurrent methadone users (95,2%). The results
show that most of the subjects live in the city, while a smaller percentage of metha-
done users (15,2%) and recurrent methadone users (4,8%) live in the country. The
Pearson's coefficient equals p= 0,034.
SBX users were mostly satisfied with their relationships with mothers and that an-
swer had been given by 57,6 % of them. Methadone users have been most satisfied
with their relationships with fathers and that answer had been given by 56,5% of
them, while the recurrent methadone users were most satisfied with their relation-
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N % N % N %
Relationship with father 2,625 0,622
Satisfied 16 48,5 26 56,5 8 38,1
ustrightNot satisfied and not unsatisfied 12 36,4 16 34,8 9 42,9
Unsatisfied 5 15,2 4 8,7 4 19,0
Relationship with mother 0,967 0,915
Satisfied 19 57,6 24 52,2 11 52,4
Not satisfied and not unsatisfied 9 27,3 16 34,8 8 38,1
Unsatisfied 5 15,2 6 13,0 2 9,5
Relationship with friends 1,091 0,896
Satisfied 16 48,5 21 45,7 12 57,1
Not satisfied and not unsatisfied 12 36,4 19 41,3 6 28,6
Unsatisfied 5 15,2 6 13,0 3 14,3
Confiding to 1,480 0,961
Friends 11 33,3 18 39,1 7 33,3
Mother 10 30,3 12 26,1 7 33,3
Father 6 18,2 6 13,0 2 9,5
Brother/Sister 6 18,2 10 21,7 5 23,8
ships with friends, 57,1% of them and least satisfied with their relationships with fa-
thers, 19,0 %. Most of the users would primarily confide to their friends, SBX 33,3%
and M+ 39,1%, while the recurrent methadone users would equally confide to their
friends and mothers, 33,3%. The answer 'father' was the least frequent in all three
groups.
It is evident that the most of recurrent methadone users were older than 30 years of
age, while the methadone users were the youngest, around thirty. There is a statisti-
cally significant difference between the groups, because the Pearson's coefficient
equals p= 0,019.
According to our data, the recurrent methadone users were the most depressive –
over 20% of their total number, while the users of subox-on and methadone were
equally depressive, around 20%. There is no statistically significant difference here,
since the Pearson's coefficient equals p = 0,216.
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Figure 1. Distribution of subjects according to age
According to our data, the subox-on users were the most anxious – 10%, while the
percentage was lower in methadone users, under 10%. There is a statistically signifi-
cant difference here, between the users of methadone M+ and recurrent methadone
users M–. The difference is significant, p = 0,216.
Among the users of SBX, the most frequently reported was 'Physical pain', equal-
ing X=63,42. The least frequently reported were 'Disturbances of physical functions',
X=37,11 and 'Limitations due to the physical difficulties' X=37,50. Among the M+
users, the most frequently reported problem was also 'Physical pain', X equaling
78,93, and the least frequently reported were 'Disturbances of physical functions',
X=24,64.
Among the recurrent methadone users, the most frequently reported were 'Distur-
bances of social functions', with X equaling 58,82 and the least frequently reported
were, same as in other groups of users, 'Disturbances of physical functions', X=33,24.
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Figure 2. Distribution of subjects according to depression
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Figure 3. Distribution of subjects according to anxiety
Table 3. Differences in domains of SF 36 Questionnaire about the quality of life
SF 36
Group
F PSBX M+ M–
X SD X SD X SD
Disturbances of physical
functions
37,11 32,72 24,64 27,84 33,24 29,21 0,697 0,503
Limitations due to physical
difficulties
37,50 36,63 41,07 28,77 44,12 39,06 0,152 0,859
Limitations due to emotional
difficulties
45,61 43,33 57,14 44,20 45,10 33,21 0,428 0,654
Vitality 56,32 18,70 53,57 10,99 45,88 18,64 1,794 0,178
Mental health 60,00 17,54 60,00 16,38 47,29 21,92 2,547 0,089
Social functioning 59,87 24,85 69,23 19,51 58,82 20,62 0,959 0,391
Physical pain 63,42 30,20 78,93 19,46 54,26 31,18 3,004 0,059
Perception of general health 49,74 16,29 51,43 9,69 40,59 18,45 2,291 0,112
DISCUSSION
Together with alcoholism, addiction to psychoactive substances is, in broader
sense, the leading social problem in the world and in the last few decades, also in our
country. Recent data show that already in later classes of primary schools, children
get their first experiences with psychoactive substances and that a significant number
of kids had already tried marijuana, let alone alcohol. All of that represents a basis, to-
gether with a superficial attitude of parents towards raising and educating their kids,
for the kids' inclination towards other types of behaviour and choosing the groups of
peers at the margins of the usual and accepted social standards, which are, in fact,
shaping the behaviour of an individual.13
According to data obtained in our study, from the total of 100 subjects, the greatest
percentage of them have finished secondary schools – SBX 72%, M+ 58,7% and M–
71,4%, while less had graduated on universities SBX 3%, M+ 6,5% and M– 0% and
colleges SBX 6,1%, M+ 6,5% and M– 4,8%. There is an interesting study, done by
the Center for Addictions of Zagreb City, which showed that the probability that kid
would try a psychoactive substance increases with higher education level of their par-
ents.14
Considering the standard of living, a lesser number of subjects reported their stan-
dard was above average, namely SBX 6,1%, M+ 6,5% and M– 0,0%, while the great-
est number reported that their standard of living was average – SBX 54,5%, M+
52,2% and M– 47,6%. Lower than average standard of living was reported by 12,1%
of SBX group, 15,2% of M+ group and 28,6% of M– group.
From the data dealing with characteristics of their households, we can see that most
of the subjects live with their families, namely SBX 54,5%, M+ 47,8% and M–
47,6%, while a smaller number of them live alone – SBX 21,2%, M+ 28,3 and M–
28,3% or with one parent – SBX 9,1%, M+ 6,5% and M– 19%. The results of Prof.
Jankovi}'s study show that one-parent families face a far greater number of difficul-
ties compared to two-parent families and show significantly less potential in all areas
of action and fulfilling the biological, psychological, emotional and social needs. The
material status of one-parent families is also significantly worse than the status of
complete families.15
Considering the interpersonal relations, our data suggest that our subjects have the
best relations with their mothers – SBX 57,6%, M+ 52,2% and M– 52,4. While the
SBX users are equally satisfied with their relationships with friends and fathers
48,5%, methadone users are more satisfied with their relationships with fathers
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(56,5%) than with their relationships with friends (45,7%) and the recurrent metha-
done users are more satisfied with their relationships with friends (57,12%) than with
their relationships with fathers (38,1%). From the study named Family and School
Fighting Against Addictions by Fabijani}, we learn that girls addicted to psychoactive
substances have rather negative opinions about their mothers. They find them frus-
trated, unsatisfied and neurotic as persons.16 As a reason for that, they report that their
mothers are not happy with their marital status and the role they have in their families,
thus developing despair about their children.
As opposed to them, the boys do not share that opinion. They do not blame their
mothers for things happening in their families, but see them as victims, suffering in
their roles because of the insecurities of their partners. Thus, the boys are more in-
clined to blame their fathers.
From our questions dealing with depression, we learn that the recurrent methadone
users were the most depressive (over 20 %), while that percentage was lower in SBX
and M+ users, equaling about 20%. We found no statistically significant differences
between these groups of subjects.
In the study carried out on addicts from Zadar, 9% of subjects had reported that de-
pression and other forms of neurotic symptoms were their main motive for their first
consumption of addictive substances.
In the studies carried out on young population of America, the data obtained show
that 18% of depressive adolescents occasionally take light drugs and 7% of them
drink alcohol at least once a week. In some other studies, the incidence of depressive
disorders among the children and adolescent addicts ranged even up to 24,7%, with a
significantly greater proportion of girls (48,2%) compared to boys (16,9%).
Analyzing the answers to questions dealing with anxiety, we can see that the SBX
users were the most anxious (10%), while the methadone users were the least anxious
(<10%). There is a significant difference between the methadone users (M+) and re-
current methadone users (M–). P-value equaled 0,034.
Considering the quality of life of our subjects, we found that the SBX users had suf-
fered mostly from physical pain (X=63,42) and least frequently from physical diffi-
culties (X=37,11) and from limitations due to the physical difficulties (X=37,50). The
methadone users had suffered mostly from physical pain (X=78,93) and least fre-
quently from physical difficulties (X=24,64). Among the recurrent methadone users,
the most frequently reported problems were the disturbances of social functions
(X=58,82) and the disturbances of physical functions were least frequently reported,
same as in other groups of subjects (X=33,24).
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CONCLUSIONS
1. According to their sex, education, standard of living and household members,
we found no statistically significant differences between our groups of subjects.
2. In all three groups of subjects, significantly more subjects lived in cities than in
rural areas p=0,034.
3. Considering the interpersonal relationships, we found no statistically significant
differences between our groups of subjects.
4. The recurrent methadone users were more depressive (>20 %), while that per-
cent is slightly lower in SBX and M+ users (around 20 %), but there were no sta-
tistically significant differences between the groups (p=0,216)
5. SBX users were the most (10%) and methadone users the least anxious (<10%).
There is a statistically significant difference between the groups, p=0,034.
6. The quality of life is lower in M– group compared to the other two groups, espe-
cially considering the following characteristics – vitality, mental health, physi-
cal pain and general perception of health, but there were no statistically signifi-
cant differences between the groups considering the quality of life.
ANKSIOZNOST I DEPRESIVNOST U OVISNIKA O OPIJATIMA LIJE^ENIH
METADONOM I BUPRENORFINOM
Sa`etak – Cilj: Ispitati anksioznost i depresiju u ovisnika o opijatima lije~enim metadonom i
buprenorfinom. Ispitanici i metode: Ispitivanje je provedeno u Udruzi 'Margina' i Centru za
prevenciju i ambulantno lije~enje ovisnika u Mostaru. Uklju~eno je 100 pacijenata podijelje-
nih u dvije skupine: prva je skupina ovisna o lijeku subox-onu (N=50) i druga skupina ovisnika
o metadonu, koja je podijeljena na dvije podskupine: M+ i M– (rekurentna). U svrhu istra-
`ivanja kori{tena je Beckova skala anksioznosti i depresivnosti, State-Trait Anxiety Inventory
(STAI) upitnik za samoprocjenu, sociodemografski upitnik koji je namjenski sa~injen za ovo
istra`ivanje i zdravstvena anketa SF-36 (Short Form Health Survey-36). Rezultati: Zna~ajno je
ve}i broj ispitanika koji `ive u gradu (p=0.034). Vi{e su deprimirani bili rekurentni korisnici
metadona (> 20%), dok je ovaj postotak bio ne{to ni`i kod korisnika SBX i u M+ skupini
(20%). Izme|u posljednje dvije skupine nije bilo statisti~ki zna~ajnih razlika (p=0.216).
Korisnici SBX pokazali su najvi{e anksioznosti (10%), dok su najmanje anksiozni bili
korisnici metadona (<10%). Postoji statisti~ki zna~ajna razlika izme|u korisnika metadona
M+ i M+ (p=0.034). Zaklju~ak: Korisnici metadona bili su zna~ajno vi{e anksiozni od
korisnika buprenorfina, dok glede depresivnosti nije na|eno statisti~ki zna~ajnih razlika.
Klju~ne rije~i: ovisnici o opijatima, anksioznost, depresivnost, metadon, buprenorfin
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